2026 Cost Planning for B2B Tech SEO

Biotech SEO isn't priced like SEO for an accounting firm or a SaaS company - and understanding why helps you evaluate proposals without getting surprised by scope creep.

Four factors push biotech engagements into a different pricing category:

• Scientific content complexity. Content targeting research directors, formulary decision-makers, or investor audiences requires writers with graduate-level science backgrounds or extensive subject-matter editing. That's a real cost. Generic blog content at $150/post won't rank for "HER2-targeted ADC mechanism of action" - and if it did, it wouldn't convert the right readers.
• Regulatory content constraints. FDA and FTC guidelines govern how pipeline assets and therapeutic claims can be framed in public-facing digital content. Agencies without biotech experience routinely produce content that creates compliance risk. Building compliant content workflows costs time and expertise.
• Audience fragmentation. A single biotech company may need to reach oncologists, payers, investors, and partnership prospects - each with different search behavior and content expectations. Multi-audience SEO requires more infrastructure than single-segment campaigns.
• Technical complexity. Biotech sites frequently carry legacy CMS issues, slow load times from heavy research-page assets, or crawling problems introduced by clinical-trial database integrations. Fixing these takes technical depth.

Agencies that quote $1,500/month for biotech SEO are almost certainly not accounting for these factors. That isn't a bargain - it's a mismatch of scope to need.

Industry benchmarks suggest that B2B technology and life sciences companies investing meaningfully in organic search spend between $4,000 and $12,000 per month on SEO-related services. Biotech skews toward the upper half of that range when content production is included in scope.

The source pricing can be read as recurring scope scenarios rather than promised outcomes. Compare the work included, who owns implementation, how scientific review is handled, which expenses are excluded, and what the team can realistically review and publish.

Tier 1: $2,500-$4,500/month - Focused Foundation ($2,500-$4,500/month)

This level is best treated as a constrained biotech SEO scope. It can cover keyword and topic research, priority on-page work, technical monitoring, measurement, and a limited content program. The decision point is whether the provider has enough access to scientific source material and reviewers to keep public claims accurate. Confirm whether implementation, digital PR, design, developer time, and extensive scientific writing are inside or outside the fee.

Tier 2: $5,000-$9,000/month - Growth Engagement

This scenario can support ongoing technical SEO, a more substantial scientific content pipeline, internal linking, refresh work, and relevant authority activity when those workstreams are explicitly scoped. For companies serving researchers, clinicians, partners, investors, or other distinct audiences, ask how the editorial plan separates their search intent instead of forcing every audience into the same page. Reporting should distinguish observable search performance and conversions from assumptions about business impact.

Tier 3: $10,000-$15,000+/month - Full-Service Engagement

A broader biotech program may add cross-program content planning, deeper technical coordination, digital PR, competitive monitoring, and more stakeholder management. The higher fee should correspond to a larger workload, more senior involvement, or more implementation responsibility, not to a guarantee of rankings, investor attention, partnership interest, or revenue. Ask which work depends on internal medical, legal, scientific, product, or communications approval and which external costs remain separate.

One-Time Projects

A comprehensive technical and content audit runs $2,500-$5,000. A full keyword architecture and content roadmap for a new pipeline asset typically runs $3,000-$8,000. Treat these as source planning ranges and compare the exact deliverables, implementation support, handoff requirements, and exclusions before deciding whether project work or an ongoing retainer fits the current backlog.

• Expert review and product accuracy - Impact: high - B2B technology pages can touch architecture, security, integrations, implementation, procurement, and product limitations. Cost rises when the provider must interview engineers, product leaders, customer-facing specialists, or other reviewers and then reconcile the draft with source documentation. The source includes a 50 to 100 cents-per-word writing range; because no supporting source URL is attached to that figure, use it as a historical planning input that still requires source reconciliation rather than a verified market rate.
• Technical implementation burden - Impact: high - Rendering problems, duplicate templates, weak internal linking, migrations, internationalization, orphaned content, conflicting canonicals, and release constraints can turn an advisory engagement into an engineering coordination program. When the initial 3-6 months are dominated by remediation, the commercial question is whether the provider is diagnosing issues, writing tickets, validating fixes, or directly implementing changes. Those are different scopes and should not be priced as though they were identical.
• Product breadth and query coverage - Impact: high - A company with one tightly defined product has a different information architecture from a vendor spanning several products, integrations, audiences, industries, and comparison sets. More surface area means more page relationships to map, more duplication risk to control, and more stakeholder context to review.
• Competitive and authority work - Impact: medium - Outreach, digital PR, expert contributions, research-led assets, and relationship development can add meaningful cost, but the proposal should explain the actual tactic, expected workload, approval process, and any external publication expense. A link count by itself does not establish quality or business value.
• Measurement maturity - Impact: medium - Clean analytics, consistent conversion definitions, CRM connectivity, and reliable landing-page tracking make reporting easier. Missing or inconsistent data can create a separate analytics workstream before pipeline contribution can be interpreted responsibly.

Budget for the retainer and for the internal or external work needed to make the recommendations usable. Scientific review, legal or medical review where applicable, web development, design, analytics support, specialist data, and approved public-relations activity can all sit outside a provider's recurring fee. A 90-day checkpoint can be useful for reviewing implementation progress, but it should not be presented as a guaranteed payback window.

• Months 1-2: Separate one-time discovery and remediation from recurring delivery. Confirm analytics access, crawl and indexation issues, priority page architecture, scientific sources, review owners, and who can implement technical changes.
• Months 3-4: Review whether approved content is being indexed, whether priority technical fixes shipped, and whether search impressions, relevant queries, landing-page engagement, or qualified conversions show directional movement. Treat early movement as evidence to investigate, not proof of a final outcome.
• Months 5-6: Reassess the recurring mix of technical work, scientific content, refreshes, internal linking, and authority activity. If progress is limited, diagnose implementation delays, weak topic fit, insufficient evidence, or competitive conditions before simply increasing spend.
• Months 9-12: In competitive therapeutic areas, sustained visibility may require a longer operating horizon. Evaluate whether the site has built useful coverage, whether important pages remain technically accessible, and whether organic discovery is contributing to the specific actions the organization can measure.

For total-cost comparison, proposals should state which work is included, which client resources are assumed, and which third-party expenses require separate approval. Measurement should focus on observable search and conversion signals rather than turning a planning timeline into an ROI promise.

Can a smaller internal team reduce outside cost?

Yes, when the team can own scientific review, content inputs, implementation, analytics, or communications. The proposal should show which responsibilities stay internal and which are purchased. Saving money by removing duplicated work is different from cutting a workstream that the program still depends on.

Should we defer SEO until the next company milestone?

A delay can be reasonable when review capacity, development access, or public information is not ready. If the source's 6-9 month planning window is relevant to your competitive context, treat it as a budgeting horizon for sustained work rather than a promise that visibility will arrive on schedule. Decide which foundational tasks are useful now and which should wait for evidence, approvals, or a clearer public narrative.

What if a previous SEO engagement underperformed?

Separate diagnosis from escalation. Review whether technical recommendations were implemented, whether scientific content matched reader intent, whether claims were supportable, whether important pages were indexable, and whether success was measured with appropriate search and conversion signals. A higher budget is justified only when the next scope addresses a documented gap.

Before choosing a larger retainer, reassess internal review capacity, implementation ownership, measurement quality, and major exclusions. The most defensible budget is the one that funds work the organization can review, implement, and measure without treating the fee itself as evidence of future results.